Cargando…
Growth Factor Proteins and Treatment-Resistant Depression: A Place on the Path to Precision
Background: Since the neurotrophic hypothesis of depression was formulated, conflicting results have been reported regarding the role of growth factor proteins in depressed patients, including whether there are state or trait alterations found in patients compared to controls and whether they repres...
Autores principales: | Pisoni, Alice, Strawbridge, Rebecca, Hodsoll, John, Powell, Timothy R., Breen, Gerome, Hatch, Stephani, Hotopf, Matthew, Young, Allan H., Cleare, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115516/ https://www.ncbi.nlm.nih.gov/pubmed/30190686 http://dx.doi.org/10.3389/fpsyt.2018.00386 |
Ejemplares similares
-
Assessing the contributions of childhood maltreatment subtypes and depression case-control status on telomere length reveals a specific role of physical neglect
por: Vincent, John, et al.
Publicado: (2017) -
Genetic predisposition to advanced biological ageing increases risk for childhood-onset recurrent major depressive disorder in a large UK sample
por: Michalek, Julia E., et al.
Publicado: (2017) -
The Role of Inflammatory Proteins in Anti-Glucocorticoid Therapy for Treatment-Resistant Depression
por: Strawbridge, Rebecca, et al.
Publicado: (2021) -
Genetic risk for severe COVID‐19 correlates with lower inflammatory marker levels in a SARS‐CoV‐2‐negative cohort
por: Powell, Timothy R, et al.
Publicado: (2021) -
Biomarkers for depression: recent insights, current challenges and future prospects
por: Strawbridge, Rebecca, et al.
Publicado: (2017)